This is Publication No. 750 of the Cancer Commission of Harvard University and No. 151 of Pondville Hospital. * From the Medical Laboratories, Collis P. Huntington Memorial Hospital (Harvard ...

2. Ovarian Cancer: Research indicates that a woman's chance of developing ovarian cancer may be influenced by hormonal ...

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...

A breast cancer diagnosis often arrives as a profound turning point, bringing uncertainty and complex emotions. While the ...

Facing a breast cancer diagnosis, especially for individuals aged 60 and above, can be difficult. However, despite the ...

Avrum Z. Bluming, MD, an expert on hormone replacement therapy, debunks the menopause misconceptions that keep women from ...

Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on ...

Breast cancer is more common after menopause than many realise, and understanding the risks, treatment options, and ...